BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25214410)

  • 21. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The insulin-like growth factor-I receptor inhibitor picropodophyllin-induced selective apoptosis of hepatocellular carcinoma cell through a caspase-dependent mitochondrial pathway.
    E C; Li J; Shao D; Zhang D; Pan Y; Chen L; Zhang X
    Oncol Res; 2013; 21(2):103-10. PubMed ID: 24406046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3].
    Ji WJ; Qu Q; Jin Y; Zhao L; He XD
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2997-3001. PubMed ID: 20137712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.
    Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Sun J; Tan CJ; Dai Z
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1595-604. PubMed ID: 19780708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
    Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
    J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
    Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
    Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allyl-isatin suppresses cell viability, induces cell cycle arrest, and promotes cell apoptosis in hepatocellular carcinoma HepG2 cells.
    Bian W; An Y; Qu H; Yang Y; Yang J; Xu Y
    Fundam Clin Pharmacol; 2016 Jun; 30(3):253-62. PubMed ID: 26945926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
    Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
    Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells.
    Handayani T; Sakinah S; Nallappan M; Pihie AH
    Anticancer Res; 2007; 27(2):965-71. PubMed ID: 17465228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats.
    Oyama K; Shiota G; Ito H; Murawaki Y; Kawasaki H
    Carcinogenesis; 2002 May; 23(5):885-92. PubMed ID: 12016164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2.
    Arce F; Gätjens-Boniche O; Vargas E; Valverde B; Díaz C
    Cancer Lett; 2005 Nov; 229(2):271-81. PubMed ID: 16135400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells.
    Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL; He DL; Zhao J
    Acta Pharmacol Sin; 2007 Dec; 28(12):1968-74. PubMed ID: 18031611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression.
    Takeda Y; Nakao K; Nakata K; Kawakami A; Ida H; Ichikawa T; Shigeno M; Kajiya Y; Hamasaki K; Kato Y; Eguchi K
    Jpn J Cancer Res; 2001 Sep; 92(9):918-25. PubMed ID: 11572758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects and mechanism of suberoylanilide hydroxamic acid on the proliferation and apoptosis of human hepatoma cell line Bel-7402.
    Wang YC; Kong WZ; Xing LH; Yang X
    J BUON; 2014; 19(3):698-704. PubMed ID: 25261655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
    Rodrigues CM; Fan G; Ma X; Kren BT; Steer CJ
    J Clin Invest; 1998 Jun; 101(12):2790-9. PubMed ID: 9637713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
    Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
    BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Zhao J; Jin J; Zhang X; Shi M; Dai J; Wu M; Wang R; Guo Y
    Cancer Gene Ther; 2006 Apr; 13(4):420-7. PubMed ID: 16211087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.